Concepedia

Niemann–Pick type C disease as proof‐of‐concept for intelligent biomarker panel selection in neurometabolic disorders

Apostolos Papandreou, Ivan Doykov, Justyna Śpiewak, Nikita Komarov, Stephanie Habermann, Manju A. Kurian, Philippa B. Mills, Kevin Mills, Paul Gissen, Wendy Heywood

Developmental Medicine & Child Neurology · 2022 · 11 citations · 25 references

DOIFull text

Open access

Abstract

Intelligent biomarker panel design can help expedite diagnosis in neurometabolic disorders. In Niemann-Pick type C disease, such a panel performed better than individual biomarkers. Biomarker panels are easy to implement and widely applicable to neurometabolic conditions.

References

25

Niemann-Pick C1 Disease Gene: Homology to Mediators of Cholesterol Homeostasis

Eugene D. Carstea, Jill A. Morris, Katherine Coleman et al. · Science · 1997 · 1.5K citations

Identification of <i>HE1</i> as the Second Gene of Niemann-Pick C Disease

Saule Naureckiene, David E. Sleat, Henry Lackland et al. · Science · 2000 · 827 citations

Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update

Marc C. Patterson, Christian J. Hendriksz, Mark Walterfang et al. · Molecular Genetics and Metabolism · 2012 · 467 citations

, , +5

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

Angela Schulz, Temitayo Ajayi, Nicola Specchio et al. · New England Journal of Medicine · 2018 · 456 citations

A defect in cholesterol esterification in Niemann-Pick disease (type C) patients.

Peter G. Pentchev, Marcella Comly, Howard S. Kruth et al. · Proceedings of the National Academy of Sciences · 1985 · 396 citations · Full text